Clinical trials sponsored by Yuhan Corporation
3
Recruiting trials
7
Conditions studied
Phase breakdown
Phase 1 2Phase 2 2Not applicable 1
Conditions studied
| Condition | Trials |
|---|---|
| Ankylosing Spondylitis | 1 |
| Breast cancer | 1 |
| HER2-Positive Solid Tumor | 1 |
| Lung cancer | 1 |
| NSCLC (Non-small Cell Lung Cancer) | 1 |
| Rheumatoid Arthritis | 1 |
| Solid Tumor | 1 |
Recruiting trials led by Yuhan Corporation
- A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS
- Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Common questions
How many trials is Yuhan Corporation recruiting for?
Yuhan Corporation is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.